Real-world effectiveness and impact of the 4CMenB vaccine against serogroup B invasive meningococcal disease: a systematic review and meta-analysis

Abstract 4CMenB vaccine is authorized for protection against serogroup B invasive meningococcal disease (IMD). This study synthesized real-world evidence (RWE) data on effectiveness and impact of 4CMenB vaccine. A systematic search identified RWE on vaccine effectiveness (VE) and vaccine impact of 4...

Descrición completa

Detalles Bibliográficos

Principais autores:	Pavo Marijic, Katarzyna Jamróz-Dolińska, Wojciech Margas, Lucian Gaianu, Gaurav Mathur, Piotr Wojciechowski, Thatiana Pinto, Tia Vincent, Helen Petousis-Harris, Terry Nolan, Federico Martinón-Torres, Lee H. Harrison, Zeki Kocaata
Formato:	Artigo
Idioma:	Inglês
Publicado:	Nature Portfolio 2026-07-01
Series:	npj Vaccines
Acceso en liña:	https://doi.org/10.1038/s41541-026-01511-y
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!